Quantcast

Latest Hologic Stories

2014-01-16 16:24:13

Providing Corporate Update on Key Projects QUEBEC CITY, Jan. 16, 2014 /PRNewswire/ - DiagnoCure, Inc. (TSX: CUR) (OTCQX: DGCRF) (the "Corporation") today reported financial and operational results for the fourth quarter 2013 and fiscal year ended October 31, 2013. The Corporation announced a net loss of $1,334,099 or $0.03 per share for the fourth quarter ended October 31, 2013, compared to $1,978,355 or $0.05 per share for the same period in 2012 and a net loss of $3,566,942 or...

2014-01-13 16:26:00

QUEBEC CITY, Jan. 13, 2014 /PRNewswire/ - DiagnoCure Inc. (TSX: CUR; OTCQX: DGCRF) announced today that the Corporation will release its fourth quarter and fiscal year 2013 operating results on January 16, 2014, at 4:00 p.m. (ET). DiagnoCure's management will host a conference call the same day, at 4:30 p.m. (ET). Interested participants may listen to the call by dialing 1-888-390-0546 or 514-225-6995 and referencing code 50137031 approximately 15 minutes prior to the call. The...

2014-01-09 08:27:42

BEDFORD, Mass., Jan. 9, 2014 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, today announced plans to release its first quarter fiscal 2014 operating results on Monday, February 3, 2014, after market close. In conjunction with the release, management will host a conference call on...

2014-01-08 08:27:40

DUBLIN, Jan. 8, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/fthv2z/biopsy_devices) has announced the addition of the "Biopsy Devices Market (Disposable & Reusable Needles, Hot & Cold Forceps, Needle-based Biopsy Guns, VAB, CNB, FNAB Devices, Guidance Systems) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Biopsy devices are...

2014-01-07 23:23:08

Volumetric Breast Density Measurement Removes Subjectivity and Improves Breast Cancer Screening Process for Radiologists and Patients West Hartfod, CT (PRWEB) January 07, 2014 Matakina International today announced that The Hospital of Central Connecticut (HOCC) is the first facility in Connecticut to adopt VolparaDensity™ breast imaging software, designed to help overcome the limitations of mammography to detect cancer in women with dense breasts. The Enterprise installation of HOCC...

2013-12-18 23:22:15

Aging European women are undergoing more breast biopsies and endometrial ablation procedures, creating a market expected to reach €684 million by 2020. Vancouver, BC (PRWEB) December 18, 2013 iData Research, the leading global authority in medical device market and pharmaceutical market research, has recently published two European reports for the women’s health device markets. These reports cover markets within fifteen European countries for bone densitometry, breast biopsy, breast...

2013-12-11 23:22:19

Visible Health and Hologic present the new drawMD patient education iPad app for Breast Health. Austin, TX (PRWEB) December 11, 2013 Visible Health announced today another collaboration with Hologic, Inc. to launch drawMD Breast Health, a free mobile application that provides breast health professionals with a powerful, proven tool for patient education. Like the other drawMD apps, drawMD Breast Health allows clinicians to create visual images that can be used to guide conversations about...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related